TY  - GEN
AU  - Robson,Mark
AU  - Im,Seock-Ah
AU  - Senkus,Elżbieta
AU  - Xu,Binghe
AU  - Domchek,Susan M
AU  - Masuda,Norikazu
AU  - Delaloge,Suzette
AU  - Li,Wei
AU  - Tung,Nadine
AU  - Armstrong,Anne
AU  - Wu,Wenting
AU  - Goessl,Carsten
AU  - Runswick,Sarah
AU  - Conte,Pierfranco
TI  - Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
SN  - 1533-4406
PY  - 2017///0822
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Disease-Free Survival
KW  - Female
KW  - Genes, BRCA1
KW  - Genes, BRCA2
KW  - Germ-Line Mutation
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Phthalazines
KW  - Piperazines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Receptor, ErbB-2
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1706450
ER  -